Erratum: A TLR7 agonist enhances the antitumor efficacy of obinutuzumab in murine lymphoma models via NK cells and CD4 T cells

Detalles Bibliográficos
Autores principales: Cheadle, E J, Lipowska-Bhalla, G, Dovedi, S J, Fagnano, E, Klein, C, Honeychurch, J, Illidge, T M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Erratum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609297/
https://www.ncbi.nlm.nih.gov/pubmed/28751765
http://dx.doi.org/10.1038/leu.2017.218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7609297/
https://www.ncbi.nlm.nih.gov/pubmed/28751765
http://dx.doi.org/10.1038/leu.2017.218

Ejemplares similares